A major international study is challenging decades of standard heart attack treatment involving beta blockers, a drug routinely prescribed to millions of patients worldwide. Researchers found that for people who experienced uncomplicated heart attacks and maintained normal heart function, beta blockers provided little to no clear long-term benefit.
The findings also raised concerns about potential risks in women, who showed a higher likelihood of death, repeat heart attacks, or hospitalization for heart failure when taking the medication compared to those who did not receive it.
Scientists say the results could reshape future treatment guidelines and highlight the need for more personalized approaches to cardiac care.
Read more at ScienceDaily
